JP2011500600A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011500600A5 JP2011500600A5 JP2010529094A JP2010529094A JP2011500600A5 JP 2011500600 A5 JP2011500600 A5 JP 2011500600A5 JP 2010529094 A JP2010529094 A JP 2010529094A JP 2010529094 A JP2010529094 A JP 2010529094A JP 2011500600 A5 JP2011500600 A5 JP 2011500600A5
- Authority
- JP
- Japan
- Prior art keywords
- ring
- benzamide
- cor
- sulfonyl
- aliphatic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CC*c(cc1)cc(*c2ccccc2)c1C(*(C)(C)c1cccc(N=O)c1)=O Chemical compound CC*c(cc1)cc(*c2ccccc2)c1C(*(C)(C)c1cccc(N=O)c1)=O 0.000 description 2
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US97928907P | 2007-10-11 | 2007-10-11 | |
| US60/979,289 | 2007-10-11 | ||
| PCT/US2008/079546 WO2009049183A1 (en) | 2007-10-11 | 2008-10-10 | Aryl amides useful as inhibitors of voltage-gated sodium channels |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011500600A JP2011500600A (ja) | 2011-01-06 |
| JP2011500600A5 true JP2011500600A5 (https=) | 2012-11-15 |
| JP5562859B2 JP5562859B2 (ja) | 2014-07-30 |
Family
ID=40373086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010529094A Expired - Fee Related JP5562859B2 (ja) | 2007-10-11 | 2008-10-10 | 電位開口型ナトリウムチャネルの阻害剤として有用なアリールアミド |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8779197B2 (https=) |
| EP (1) | EP2212290B1 (https=) |
| JP (1) | JP5562859B2 (https=) |
| KR (1) | KR20100075631A (https=) |
| CN (1) | CN101883758A (https=) |
| AU (1) | AU2008310663A1 (https=) |
| CA (1) | CA2702101A1 (https=) |
| IL (1) | IL204978A0 (https=) |
| MX (1) | MX2010003865A (https=) |
| NZ (1) | NZ584519A (https=) |
| RU (1) | RU2010118467A (https=) |
| WO (1) | WO2009049183A1 (https=) |
| ZA (1) | ZA201002604B (https=) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2683788C2 (ru) * | 2013-01-31 | 2019-04-02 | Вертекс Фармасьютикалз Инкорпорейтед | Амиды хинолина и хиназолина, полезные в качестве модуляторов натриевых каналов |
| CA2898653C (en) * | 2013-01-31 | 2021-09-28 | Vertex Pharmaceuticals Incorporated | Amides as modulators of sodium channels |
| RS56015B1 (sr) | 2013-01-31 | 2017-09-29 | Vertex Pharma | Piridon amidi kao modulatori natrijumovih kanala |
| UA119147C2 (uk) * | 2013-07-19 | 2019-05-10 | Вертекс Фармасьютікалз Інкорпорейтед | Сульфонаміди як модулятори натрієвих каналів |
| CA2931550C (en) * | 2013-12-13 | 2023-09-26 | Vertex Pharmaceuticals Incorporated | Prodrugs of pyridone amides useful as modulators of sodium channels |
| NZ742038A (en) * | 2015-10-07 | 2019-08-30 | Univ Arizona | Crmp2 sumoylation inhibitors and uses thereof |
| EP3625214B1 (en) | 2017-05-16 | 2022-07-06 | Vertex Pharmaceuticals Incorporated | Deuterated pyridone amides and prodrugs thereof as modulators of sodium channels |
| AU2018300150A1 (en) | 2017-07-11 | 2020-01-30 | Vertex Pharmaceuticals Incorporated | Carboxamides as modulators of sodium channels |
| US11529337B2 (en) | 2018-02-12 | 2022-12-20 | Vertex Pharmaceuticals Incorporated | Method of treating pain |
| AU2019302534B2 (en) | 2018-07-09 | 2024-10-03 | Lieber Institute, Inc. | Pyridazine compounds for inhibiting NaV1.8 |
| CA3105657A1 (en) | 2018-07-09 | 2020-01-16 | Lieber Institute, Inc. | Pyridine carboxamide compounds for inhibiting nav1.8 |
| JP7288051B2 (ja) * | 2018-11-02 | 2023-06-06 | メルク・シャープ・アンド・ドーム・エルエルシー | Ｎａｖ１．８阻害薬としての２－アミノ－Ｎ－ヘテロアリール－ニコチンアミド類 |
| US12344595B2 (en) | 2018-11-02 | 2025-07-01 | Merck Sharp & Dohme Llc | 2-amino-n-phenyl-nicotinamides as NAV1.8 inhibitors |
| US20220073471A1 (en) * | 2019-01-04 | 2022-03-10 | Jiangsu Hengrui Medicine Co., Ltd. | 6-oxo-1,6-dihydropyridazine derivative, preparation method therefor and medical use thereof |
| US12440481B2 (en) | 2019-01-10 | 2025-10-14 | Vertex Pharmaceuticals Incorporated | Esters and carbamates as modulators of sodium channels |
| WO2020146682A1 (en) * | 2019-01-10 | 2020-07-16 | Vertex Pharmaceuticals Incorporated | Carboxamides as modulators of sodium channels |
| WO2020169042A1 (zh) * | 2019-02-20 | 2020-08-27 | 江苏恒瑞医药股份有限公司 | 6-氧代-1,6-二氢哒嗪类前药衍生物、其制备方法及其在医药上的应用 |
| CN112390745B (zh) * | 2019-08-19 | 2022-10-21 | 江苏恒瑞医药股份有限公司 | 吡啶烟酰胺类衍生物、其制备方法及其在医药上的应用 |
| BR112022004495A8 (pt) * | 2019-09-12 | 2023-04-18 | Jiangxi Jemincare Group Co Ltd | Compostos oxinitreto de piridina, composição farmacêutica compreendendo os mesmos e usos dos mesmos |
| BR112022010924A2 (pt) | 2019-12-06 | 2022-09-06 | Vertex Pharma | Tetra-hidrofuranos substituídos como moduladores de canais de sódio |
| CN114437062B (zh) * | 2020-04-30 | 2024-05-17 | 成都海博为药业有限公司 | 一种可作为钠通道调节剂的化合物及其用途 |
| US11802122B2 (en) | 2020-06-17 | 2023-10-31 | Merck Sharp & Dohme Llc | 2-oxoimidazolidine-4-carboxamides as NAv1.8 inhibitors |
| US12516046B2 (en) | 2020-06-17 | 2026-01-06 | Merck Sharp & Dohme Llc | 2-oxo-oxazolidine-5-carboxamides as NAV1.8 inhibitors |
| CN114031518B (zh) * | 2020-12-08 | 2023-08-18 | 成都海博为药业有限公司 | 一种苄胺或苄醇衍生物及其用途 |
| GEP20257795B (en) | 2021-05-07 | 2025-09-25 | Merck Sharp & Dohme Llc | Cycloalkyl 3-oxopiperazine carboxamides and cycloheteroalkyl 3-oxopiperazine carboxamides as nav1.8 inhibitors |
| SMT202500481T1 (it) | 2021-06-04 | 2026-01-12 | Vertex Pharma | N-(idrossialchil(etero)aril)tetraidrofuran carbossammidi come modulatori di canali del sodio |
| TW202317520A (zh) | 2021-06-15 | 2023-05-01 | 德商歌林達有限公司 | 經取代之吡唑醯胺 |
| WO2023205463A1 (en) | 2022-04-22 | 2023-10-26 | Vertex Pharmaceuticals Incorporated | Heteroaryl compounds for the treatment of pain |
| IL319389A (en) * | 2022-09-09 | 2025-05-01 | Latigo Biotherapeutics Inc | Sodium channel blocking compounds, derivatives thereof, and methods of using them |
| EP4385980A1 (en) | 2022-12-14 | 2024-06-19 | Grünenthal GmbH | Indazoles as inhibitors of nav1.8 |
| EP4385979A1 (en) | 2022-12-14 | 2024-06-19 | Grünenthal GmbH | Multicyclic inhibitors of nav1.8 |
| AR131345A1 (es) | 2022-12-14 | 2025-03-12 | Gruenenthal Gmbh | SULFOXIMINAS COMO INHIBIDORES DE NaV1.8 |
| EP4385984A1 (en) | 2022-12-14 | 2024-06-19 | Grünenthal GmbH | Pyridine-n-oxides as inhibitors of nav1.8 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE568114A (https=) | 1957-05-29 | 1900-01-01 | ||
| ES482591A1 (es) | 1978-07-20 | 1980-04-01 | Basf Ag | Procedimiento para la obtencion de n-arilsulfonilpirroles. |
| PE20010306A1 (es) * | 1999-07-02 | 2001-03-29 | Agouron Pharma | Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa |
| US6620849B2 (en) * | 2000-07-26 | 2003-09-16 | Icafen, Inc. | Potassium channel inhibitors |
| US6995162B2 (en) | 2001-01-12 | 2006-02-07 | Amgen Inc. | Substituted alkylamine derivatives and methods of use |
| US7105682B2 (en) | 2001-01-12 | 2006-09-12 | Amgen Inc. | Substituted amine derivatives and methods of use |
| WO2003037274A2 (en) | 2001-11-01 | 2003-05-08 | Icagen, Inc. | Pyrazole-amides and-sulfonamides |
| SE0203752D0 (sv) | 2002-12-17 | 2002-12-17 | Astrazeneca Ab | New compounds |
| WO2004106324A1 (en) | 2003-05-27 | 2004-12-09 | E.I. Dupont De Nemours And Company | Azolecarboxamide herbicides |
| EP1673357A2 (en) * | 2003-08-08 | 2006-06-28 | Vertex Pharmaceuticals Incorporated | Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| WO2006053227A2 (en) | 2004-11-10 | 2006-05-18 | Synta Pharmaceuticals Corp. | Il-12 modulatory compounds |
| MX295245B (es) * | 2005-06-21 | 2012-01-26 | Mitsui Chemicals Inc | Derivado de amida e insecticida que contiene el mismo. |
| DOP2006000210A (es) | 2005-10-04 | 2007-06-15 | Aventis Pharma Inc | Compuestos de pirimidina amida como inhibidores de pgds |
| EP2004596A2 (en) * | 2006-04-11 | 2008-12-24 | Vertex Pharmaceuticals Incorporated | Compositions useful as inhibitors of voltage-gated sodium channels |
-
2008
- 2008-10-10 KR KR1020107010357A patent/KR20100075631A/ko not_active Withdrawn
- 2008-10-10 JP JP2010529094A patent/JP5562859B2/ja not_active Expired - Fee Related
- 2008-10-10 EP EP08838261.9A patent/EP2212290B1/en active Active
- 2008-10-10 US US12/249,270 patent/US8779197B2/en active Active
- 2008-10-10 MX MX2010003865A patent/MX2010003865A/es active IP Right Grant
- 2008-10-10 WO PCT/US2008/079546 patent/WO2009049183A1/en not_active Ceased
- 2008-10-10 CN CN2008801184861A patent/CN101883758A/zh active Pending
- 2008-10-10 NZ NZ584519A patent/NZ584519A/en not_active IP Right Cessation
- 2008-10-10 AU AU2008310663A patent/AU2008310663A1/en not_active Abandoned
- 2008-10-10 RU RU2010118467/04A patent/RU2010118467A/ru not_active Application Discontinuation
- 2008-10-10 CA CA2702101A patent/CA2702101A1/en not_active Abandoned
-
2010
- 2010-04-08 IL IL204978A patent/IL204978A0/en unknown
- 2010-04-14 ZA ZA2010/02604A patent/ZA201002604B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011500600A5 (https=) | ||
| RU2010118467A (ru) | Ариламиды, пригодные в качестве ингибиторов потенциалзависимых натриевых каналов | |
| JP2011500599A5 (https=) | ||
| KR101235961B1 (ko) | 프로스타글란딘 ｄ２ 수용체의 ｎ,ｎ-이치환 아미노알킬비페닐 길항제 | |
| WO2010003127A2 (en) | Antagonists of prostaglandin d2 receptors | |
| RU2008144415A (ru) | Композиции, полезные в качестве ингибиторов потенциалзависимых натриевых каналов | |
| RU2010118481A (ru) | Амиды, применимые в качестве ингибиторов потенциалзависимых натриевых каналов | |
| EP2245022A2 (en) | Antagonists of prostaglandin d2 receptors | |
| AU2019226215A1 (en) | Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases | |
| JP2011512359A (ja) | プロスタグランジンｄ２受容体のアンタゴニストとしての環式ジアリールエーテル化合物 | |
| ES2232114T3 (es) | Derivados de cicloalqueno, procedimiento para su produccion, y uso. | |
| JP2011518130A (ja) | プロスタグランジンｄ２受容体のアミノアルキルフェニルアンタゴニスト | |
| JP2012515166A5 (https=) | ||
| CN1474818A (zh) | 含有稠合杂环化合物或其盐的糖尿病预防或治疗药 | |
| JP2016500661A5 (https=) | ||
| JP2014500330A5 (https=) | ||
| JP2010513334A (ja) | Ｐｄｅ４阻害剤として有用な置換アセトフェノン | |
| RU2014119269A (ru) | Полиморфы arry-380, селективного ингибитора erb2, и фармацевтические составы, содержащие их | |
| CN1361763A (zh) | 作为IL－1β和TNF－α的抑制剂的氨基二苯酮 | |
| JP4580866B2 (ja) | Ｔａｃｅのインヒビター | |
| RU2247719C2 (ru) | Аминобензофеноны как ингибиторы il-1 бета и tnf-альфа, фармацевтическая композиция и способ лечения и/или профилактики воспалительных заболеваний | |
| CN103384522B (zh) | 咖啡酸衍生物和它们在改善神经细胞生存力中的用途 | |
| US10391076B2 (en) | Anti-cancer agent comprising aminoacetonitrile compound as active ingredient | |
| EP2547199A2 (fr) | Nouvelles utilisations de composes de type esteramide | |
| RU2006112573A (ru) | Соединения карбоновых кислот и медицинские композиции, содержащие их в качестве активного ингредиента |